ICICI Prudential Mutual Fund
When comparing, both lines start at 100. Tradinity's reference for the category: a total-return index (dividends reinvested). The fund's declared benchmark (BSE Healthcare TRI) is not available to us as a series.
This is an IDCW (dividend) option: it pays cash out of its NAV, so returns computed from the NAV alone would understate what an investor earned.
Computed from this fund's actual NAVs. A SIP buys at the first NAV of each month and is valued at the latest NAV. Past returns do not guarantee future ones.
Weights are % of the scheme's assets from the latest month-end disclosure available to Tradinity. Shown from the Direct plan of this fund, which holds the same portfolio. The feed carries weights only: no quantities or rupee values.
Valuation ratios are weighted over the holdings we can match to a company (harmonic mean for P/E) and are withheld when they cover under half the portfolio.
| Equity | 95.01% |
| Cash & Equivalents | 4.99% |
Click a sector to filter the holdings below (holdings map to our sector list where the company is known).
| Holding | Sector | Weight | 3M change | P/E |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.31% | 0.11 pp | 143.5 |
| Dr. Reddy's Laboratories Limited | Healthcare | 8.26% | 0.04 pp | 150.9 |
| Cipla Ltd | Healthcare | 5.76% | -0.91 pp | 35.1 |
| Mankind Pharma Ltd | Healthcare | 5.21% | -1.77 pp | 46.9 |
| Alkem Laboratories Ltd | Healthcare | 4.87% | -0.80 pp | 29.1 |
| Divi's Laboratories Ltd | Healthcare | 4.83% | -0.74 pp | 83.0 |
| TREPS | — | 4.78% | 0.99 pp | — |
| Biocon Limited | Healthcare | 4.68% | 2.09 pp | 596.5 |
| MedPlus Health Services Limited | Consumer Services | 4.15% | 0.49 pp | 116.5 |
| Cohance Lifesciences Ltd | Healthcare | 4.08% | -0.23 pp | 96.3 |
| Syngene International Ltd | Healthcare | 3.29% | 0.40 pp | 62.8 |
| Dr. Agarwal's Health Care Limited | Healthcare | 2.79% | 2.79 pp | 334.0 |
| Max Healthcare Institute Limited | Healthcare | 2.59% | -0.50 pp | 124.3 |
| Alembic Pharmaceuticals Ltd | Healthcare | 2.48% | -0.10 pp | 22.3 |
| Abbott India Ltd | Healthcare | 2.38% | -0.09 pp | 34.5 |
| Akums Drugs and Pharmaceuticals Ltd | Healthcare | 1.99% | -0.06 pp | 109.9 |
| Astrazeneca Pharma India Ltd | Healthcare | 1.99% | 1.16 pp | 87.1 |
| Lupin Limited | Healthcare | 1.96% | -0.34 pp | 13.2 |
| Blue Jet Healthcare Ltd | Healthcare | 1.93% | 0.42 pp | 39.2 |
| Indegene Ltd | Healthcare | 1.92% | 1.92 pp | 63.4 |
| Pfizer Ltd | Healthcare | 1.86% | -0.00 pp | 23.9 |
| Metropolis Healthcare Ltd | Healthcare | 1.74% | 0.32 pp | 28.1 |
| Rainbow Children's Medicare Ltd | Healthcare | 1.36% | -0.08 pp | 51.3 |
| Thyrocare Technologies Limited | Healthcare | 1.30% | -0.94 pp | 34.6 |
| Entero Healthcare Solutions Ltd | Consumer Services | 1.23% | -0.46 pp | 316.6 |
| Fine Organic Industries Ltd | Chemicals | 1.22% | -0.11 pp | 41.1 |
| Alivus Life Sciences Ltd | Healthcare | 1.21% | -0.33 pp | 28.0 |
| Medi Assist Healthcare Services Ltd | Financial Services | 1.13% | -0.20 pp | 38.1 |
| Aarti Drugs Ltd | Healthcare | 1.10% | 0.03 pp | 22.1 |
| Hikal Ltd | Healthcare | 1.05% | -0.29 pp | — |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.97% | -0.17 pp | 32.5 |
| Manipal Health Enterprises Limited | Healthcare | 0.92% | 0.92 pp | — |
| Laxmi Dental Ltd | Healthcare | 0.67% | -0.10 pp | 59.2 |
| FDC Limited | Healthcare | 0.62% | -0.17 pp | 18.2 |
| Indoco Remedies Ltd | Healthcare | 0.58% | -0.02 pp | 21.8 |
| Windlas Biotech Ltd | Healthcare | 0.57% | -0.20 pp | 32.2 |
| Net Current Assets | — | 0.20% | 0.04 pp | — |
| Cash Margin - Derivatives | — | 0.01% | -0.00 pp | — |
This is a paid feature
Comparing more months of this fund's own portfolio history is available on paid plans.
Sign inExpense ratio by month: Aug 26 2.07% · Sep 26 2.07%
1% of the applicable NAV - If units purchased or switched in from another scheme of the Fund are redeemed or switched out within 15 days from the date of allotment; NIL - If units purchased or switched in from another scheme of the Fund are redeemed or switched out after 15 days from the date of allotment (w.e.f. 1st Jan 2019)
To generate long term capital appreciation through investments made primarily in equity & equity related securities of companies forming part of Healthcare sector.; However there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
Fund house: website · factsheets · monthly portfolio · annual report
Not available: Morningstar rating (proprietary). "NAV history from" is the first NAV we hold.
Returns are computed by Tradinity from each scheme's own published NAV, so they are net of the fund's expenses. Periods over one year are annualised (CAGR). Past performance does not indicate future returns. Only Growth-option schemes are ranked: an IDCW scheme pays cash out of its NAV, so its NAV understates what an investor earned.
